Sycai Medical 1-Pager

Description

Pancreatic cystic lesions can evolve into pancreatic cancer, the 4th leading cause of death by cancer in Europe, and accurate and early detection of thee lesions is critical to identify people who may be at risk. That's why Sycai medical developed a solution to help radiologists detect pancreatic cystic lesions through Ai imaging analysis of CT scans. The solution empowers healthcare professionals to provide more precise diagnoses, monitor cystic lesions throughout their treatments, and aid in the prediction of their evolution. This assistive technology can identify, classify, and predict cysts that may be malignant, and cysts that are staying benign. Through the Intel distribution of OpenVINO Sycai Medical is able to make these cystic predictions faster and more accurate, enabling physicians to be more effective, efficient, and to improve patient care.